253 related articles for article (PubMed ID: 25169989)
21. Combined treatment with bexarotene and rosuvastatin reduces angiotensin-II-induced abdominal aortic aneurysm in apoE(-/-) mice and angiogenesis.
Escudero P; Navarro A; Ferrando C; Furio E; Gonzalez-Navarro H; Juez M; Sanz MJ; Piqueras L
Br J Pharmacol; 2015 Jun; 172(12):2946-60. PubMed ID: 25630951
[TBL] [Abstract][Full Text] [Related]
22. Activation of RXR/PPARγ underlies neuroprotection by bexarotene in ischemic stroke.
Certo M; Endo Y; Ohta K; Sakurada S; Bagetta G; Amantea D
Pharmacol Res; 2015 Dec; 102():298-307. PubMed ID: 26546745
[TBL] [Abstract][Full Text] [Related]
23. Activation of retinoid X receptor by bexarotene attenuates neuroinflammation via PPARγ/SIRT6/FoxO3a pathway after subarachnoid hemorrhage in rats.
Zuo Y; Huang L; Enkhjargal B; Xu W; Umut O; Travis ZD; Zhang G; Tang J; Liu F; Zhang JH
J Neuroinflammation; 2019 Feb; 16(1):47. PubMed ID: 30791908
[TBL] [Abstract][Full Text] [Related]
24. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists.
Mukherjee R; Davies PJ; Crombie DL; Bischoff ED; Cesario RM; Jow L; Hamann LG; Boehm MF; Mondon CE; Nadzan AM; Paterniti JR; Heyman RA
Nature; 1997 Mar; 386(6623):407-10. PubMed ID: 9121558
[TBL] [Abstract][Full Text] [Related]
25. Monocyte chemoattractant protein-1 mediates angiotensin II-induced vascular smooth muscle cell proliferation via SAPK/JNK and ERK1/2.
Yao HL; Gao FH; Li ZZ; Wu HX; Xu MD; Zhang Z; Dai QY
Mol Cell Biochem; 2012 Jul; 366(1-2):355-62. PubMed ID: 22527942
[TBL] [Abstract][Full Text] [Related]
26. Bexarotene, a Selective RXRα Agonist, Reverses Hypotension Associated with Inflammation and Tissue Injury in a Rat Model of Septic Shock.
Tunctan B; Kucukkavruk SP; Temiz-Resitoglu M; Guden DS; Sari AN; Sahan-Firat S
Inflammation; 2018 Feb; 41(1):337-355. PubMed ID: 29188497
[TBL] [Abstract][Full Text] [Related]
27. Telmisartan-induced inhibition of vascular cell proliferation beyond angiotensin receptor blockade and peroxisome proliferator-activated receptor-gamma activation.
Yamamoto K; Ohishi M; Ho C; Kurtz TW; Rakugi H
Hypertension; 2009 Dec; 54(6):1353-9. PubMed ID: 19822796
[TBL] [Abstract][Full Text] [Related]
28. Retinoids inhibit the actions of angiotensin II on vascular smooth muscle cells.
Haxsen V; Adam-Stitah S; Ritz E; Wagner J
Circ Res; 2001 Mar; 88(6):637-44. PubMed ID: 11282899
[TBL] [Abstract][Full Text] [Related]
29. High glucose conditions induce upregulation of fractalkine and monocyte chemotactic protein-1 in human smooth muscle cells.
Dragomir E; Manduteanu I; Calin M; Gan AM; Stan D; Koenen RR; Weber C; Simionescu M
Thromb Haemost; 2008 Dec; 100(6):1155-65. PubMed ID: 19132243
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of interleukin-1beta-induced group IIA secretory phospholipase A2 expression by peroxisome proliferator-activated receptors (PPARs) in rat vascular smooth muscle cells: cooperation between PPARbeta and the proto-oncogene BCL-6.
Ravaux L; Denoyelle C; Monne C; Limon I; Raymondjean M; El Hadri K
Mol Cell Biol; 2007 Dec; 27(23):8374-87. PubMed ID: 17908795
[TBL] [Abstract][Full Text] [Related]
31. PPARδ coordinates angiotensin II-induced senescence in vascular smooth muscle cells through PTEN-mediated inhibition of superoxide generation.
Kim HJ; Ham SA; Kim MY; Hwang JS; Lee H; Kang ES; Yoo T; Woo IS; Yabe-Nishimura C; Paek KS; Kim JH; Seo HG
J Biol Chem; 2011 Dec; 286(52):44585-93. PubMed ID: 22072715
[TBL] [Abstract][Full Text] [Related]
32. Induced differentiation of acute myeloid leukemia cells by activation of retinoid X and liver X receptors.
Sanchez PV; Glantz ST; Scotland S; Kasner MT; Carroll M
Leukemia; 2014 Apr; 28(4):749-60. PubMed ID: 23823656
[TBL] [Abstract][Full Text] [Related]
33. PPARgamma agonist, rosiglitazone, regulates angiotensin II-induced vascular inflammation through the TLR4-dependent signaling pathway.
Ji Y; Liu J; Wang Z; Liu N; Gou W
Lab Invest; 2009 Aug; 89(8):887-902. PubMed ID: 19451898
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological activation of PPARγ inhibits hypoxia-induced proliferation through a caveolin-1-targeted and -dependent mechanism in PASMCs.
Yang K; Zhao M; Huang J; Zhang C; Zheng Q; Chen Y; Jiang H; Lu W; Wang J
Am J Physiol Cell Physiol; 2018 Apr; 314(4):C428-C438. PubMed ID: 29351409
[TBL] [Abstract][Full Text] [Related]
35. Early endosomal antigen 1 (EEA1) is an obligate scaffold for angiotensin II-induced, PKC-alpha-dependent Akt activation in endosomes.
Nazarewicz RR; Salazar G; Patrushev N; San Martin A; Hilenski L; Xiong S; Alexander RW
J Biol Chem; 2011 Jan; 286(4):2886-95. PubMed ID: 21097843
[TBL] [Abstract][Full Text] [Related]
36. FXR-mediated regulation of angiotensin type 2 receptor expression in vascular smooth muscle cells.
Zhang Q; He F; Kuruba R; Gao X; Wilson A; Li J; Billiar TR; Pitt BR; Xie W; Li S
Cardiovasc Res; 2008 Feb; 77(3):560-9. PubMed ID: 18006431
[TBL] [Abstract][Full Text] [Related]
37. Shear stress induces synthetic-to-contractile phenotypic modulation in smooth muscle cells via peroxisome proliferator-activated receptor alpha/delta activations by prostacyclin released by sheared endothelial cells.
Tsai MC; Chen L; Zhou J; Tang Z; Hsu TF; Wang Y; Shih YT; Peng HH; Wang N; Guan Y; Chien S; Chiu JJ
Circ Res; 2009 Aug; 105(5):471-80. PubMed ID: 19628794
[TBL] [Abstract][Full Text] [Related]
38. PPARγ regulates resistance vessel tone through a mechanism involving RGS5-mediated control of protein kinase C and BKCa channel activity.
Ketsawatsomkron P; Lorca RA; Keen HL; Weatherford ET; Liu X; Pelham CJ; Grobe JL; Faraci FM; England SK; Sigmund CD
Circ Res; 2012 Nov; 111(11):1446-58. PubMed ID: 22962432
[TBL] [Abstract][Full Text] [Related]
39. Angiotensin II shifts insulin signaling into vascular remodeling from glucose metabolism in vascular smooth muscle cells.
Hitomi H; Kaifu K; Fujita Y; Sofue T; Nakano D; Moriwaki K; Hara T; Kiyomoto H; Kohno M; Kobori H; Nishiyama A
Am J Hypertens; 2011 Oct; 24(10):1149-55. PubMed ID: 21716329
[TBL] [Abstract][Full Text] [Related]
40. Peroxisome proliferator-activated receptor-γ mutations responsible for lipodystrophy with severe hypertension activate the cellular renin-angiotensin system.
Auclair M; Vigouroux C; Boccara F; Capel E; Vigeral C; Guerci B; Lascols O; Capeau J; Caron-Debarle M
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):829-38. PubMed ID: 23393388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
